Remedent, Inc. Stock Other OTC
Equities
REMI
US75954T1043
Medical Equipment, Supplies & Distribution
Sales 2022 | 402K 550K | Sales 2023 | 46.11K 63.09K | Capitalization | 3.07M 4.19M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 7.44 x |
Net cash position 2022 | 2.52K 3.45K | Net cash position 2023 | 27.69K 37.88K | EV / Sales 2023 | 65.9 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.46% |
Managers | Title | Age | Since |
---|---|---|---|
Guy de Vreese
CEO | Chief Executive Officer | 69 | 02-03-31 |
Director of Finance/CFO | 59 | 05-03-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Kolsteeg
BRD | Director/Board Member | 81 | 02-03-31 |
Guy de Vreese
CEO | Chief Executive Officer | 69 | 02-03-31 |
Director of Finance/CFO | 59 | 05-03-29 |
1st Jan change | Capi. | |
---|---|---|
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |